Letters to the editor: Sir: We read with great interest the article by Englert and colleagues on their experiences with sulphasalazine treatment in rheumatoid arthritis (RA).' They noted the disappearance of rheumatoid nodules in four patients with RA in eight to 12 weeks after the start of treatment, parallel with a decrease in disease activity.